$BBIO.US – ranked positive on January 4th, 2022

$BBIO.US – ranked positive on January 4th, 2022

Bridgebio Pharma Inc – (BBIO, +N, Jan 4th)

Six Non-Executives bought a total of $2.8 million of stock across a series of purchases on the 29th and 30th December at approx $14. In each case, this is their first purchase in the stock having joined the board in 2020 or 2021 (James Momtazee is the exception, he joined in 2016).

The shares have been extremely weak since disappointing clinical trial results in December 2021. Whilst this is likely a coordinated set of purchases and we would like to see executives join the buying, this is still a meaningful cluster of purchases.

We are ranking the stock +N.

If you want to have Stock of the Week with insider buying stocks information and analysis in your email, don’t forget to subscribe!
Follow us on LinkedIn and Twitter

Check our Signals Performance and if you want to know more about this Signals Service, please, email us at sales_admin@smartinsider.com or fill in the Contact Us form here.

If you are interested in our Stocks of the Week
those services may also be useful for you

Desktop
Service

Timely data delivery customised to every user, backed by analysis tools on our internal website

Signals
Data

We rank the stocks where transactions are most likely to indicate future share price performance

Shares
Buybacks

Studying buyback activity can give a clue to the fortunes of a company and help predict future share price movement

If you are a member of the media and would like to speak with a Smart Insider expert, please contact us press@smartinsider.com or call +44 203 405 3356

Scroll to Top